158 related articles for article (PubMed ID: 35754823)
41. Epistasis among HLA-DRB1, HLA-DQA1, and HLA-DQB1 loci determines multiple sclerosis susceptibility.
Lincoln MR; Ramagopalan SV; Chao MJ; Herrera BM; Deluca GC; Orton SM; Dyment DA; Sadovnick AD; Ebers GC
Proc Natl Acad Sci U S A; 2009 May; 106(18):7542-7. PubMed ID: 19380721
[TBL] [Abstract][Full Text] [Related]
42. Differences in autoantibody response to Th/To between systemic sclerosis and other autoimmune diseases.
Kuwana M; Kimura K; Hirakata M; Kawakami Y; Ikeda Y
Ann Rheum Dis; 2002 Sep; 61(9):842-6. PubMed ID: 12176814
[TBL] [Abstract][Full Text] [Related]
43. Connective tissue disease and autoantibodies in the kindreds of 63 patients with systemic sclerosis. The United Kingdom Systemic Sclerosis Study Group.
Maddison PJ; Stephens C; Briggs D; Welsh KI; Harvey G; Whyte J; McHugh N; Black CM
Medicine (Baltimore); 1993 Mar; 72(2):103-12. PubMed ID: 8479323
[TBL] [Abstract][Full Text] [Related]
44. HLA and killer cell immunoglobulin-like receptor (KIRs) genotyping in patients with acute ischemic stroke.
Tuttolomondo A; Di Raimondo D; Pecoraro R; Casuccio A; Di Bona D; Aiello A; Accardi G; Arnao V; Clemente G; Corte VD; Maida C; Simonetta I; Caruso C; Squatrito R; Pinto A;
J Neuroinflammation; 2019 Apr; 16(1):88. PubMed ID: 30995924
[TBL] [Abstract][Full Text] [Related]
45. Analysis of Killer Cell Immunoglobulin-like Receptor Genes and Their HLA Ligands in Iranian Patients with Ankylosing Spondylitis.
Mahmoudi M; Jamshidi AR; Karami J; Mohseni A; Amirzargar AA; Farhadi E; Ahmadzadeh N; Nicknam MH
Iran J Allergy Asthma Immunol; 2016 Feb; 15(1):27-38. PubMed ID: 26996109
[TBL] [Abstract][Full Text] [Related]
46. Receptor-ligand analyses define minimal killer cell Ig-like receptor (KIR) in humans.
Du Z; Gjertson DW; Reed EF; Rajalingam R
Immunogenetics; 2007 Jan; 59(1):1-15. PubMed ID: 17103212
[TBL] [Abstract][Full Text] [Related]
47. Imbalance of Genes Encoding Natural Killer Immunoglobulin-Like Receptors and Human Leukocyte Antigen in Patients With Biliary Cancer.
Cornillet M; Jansson H; Schaffer M; Hertwig L; Berglin L; Zimmer CL; Johansson H; Ellis E; Isaksson B; Gonzalez-Galarza FF; Middleton D; Malmberg KJ; Sparrelid E; Björkström NK
Gastroenterology; 2019 Oct; 157(4):1067-1080.e9. PubMed ID: 31229495
[TBL] [Abstract][Full Text] [Related]
48. Roles for HLA and KIR polymorphisms in natural killer cell repertoire selection and modulation of effector function.
Yawata M; Yawata N; Draghi M; Little AM; Partheniou F; Parham P
J Exp Med; 2006 Mar; 203(3):633-45. PubMed ID: 16533882
[TBL] [Abstract][Full Text] [Related]
49. HLA-DPB1 and DPB2 are genetic loci for systemic sclerosis: a genome-wide association study in Koreans with replication in North Americans.
Zhou X; Lee JE; Arnett FC; Xiong M; Park MY; Yoo YK; Shin ES; Reveille JD; Mayes MD; Kim JH; Song R; Choi JY; Park JA; Lee YJ; Lee EY; Song YW; Lee EB
Arthritis Rheum; 2009 Dec; 60(12):3807-14. PubMed ID: 19950302
[TBL] [Abstract][Full Text] [Related]
50. Genetic epistasis between killer immunoglobulin-like receptors and human leukocyte antigens in Kawasaki disease susceptibility.
Bossi G; Mannarino S; Pietrogrande MC; Salice P; Dellepiane RM; Cremaschi AL; Corana G; Tozzo A; Capittini C; De Silvestri A; Tinelli C; Pasi A; Martinetti M
Genes Immun; 2015 Oct; 16(7):481-7. PubMed ID: 26335810
[TBL] [Abstract][Full Text] [Related]
51. Polymorphisms of KIRs gene and HLA-C alleles in patients with ankylosing spondylitis: possible association with susceptibility to the disease.
Jiao YL; Ma CY; Wang LC; Cui B; Zhang J; You L; Chen ZJ; Li JF; Zhao YR
J Clin Immunol; 2008 Jul; 28(4):343-9. PubMed ID: 18297378
[TBL] [Abstract][Full Text] [Related]
52. Defining KIR and HLA Class I Genotypes at Highest Resolution via High-Throughput Sequencing.
Norman PJ; Hollenbach JA; Nemat-Gorgani N; Marin WM; Norberg SJ; Ashouri E; Jayaraman J; Wroblewski EE; Trowsdale J; Rajalingam R; Oksenberg JR; Chiaroni J; Guethlein LA; Traherne JA; Ronaghi M; Parham P
Am J Hum Genet; 2016 Aug; 99(2):375-91. PubMed ID: 27486779
[TBL] [Abstract][Full Text] [Related]
53. HLA and autoimmunity in scleroderma (systemic sclerosis).
Arnett FC
Int Rev Immunol; 1995; 12(2-4):107-28. PubMed ID: 7650416
[TBL] [Abstract][Full Text] [Related]
54. Association of killer cell immunoglobulin-like receptor genotypes with microscopic polyangiitis.
Miyashita R; Tsuchiya N; Yabe T; Kobayashi S; Hashimoto H; Ozaki S; Tokunaga K
Arthritis Rheum; 2006 Mar; 54(3):992-7. PubMed ID: 16508981
[TBL] [Abstract][Full Text] [Related]
55. KIR/HLA genotypes confer susceptibility and progression in patients with autoimmune hepatitis.
Umemura T; Joshita S; Saito H; Yoshizawa K; Norman GL; Tanaka E; Ota M
JHEP Rep; 2019 Nov; 1(5):353-360. PubMed ID: 32039386
[TBL] [Abstract][Full Text] [Related]
56. Hierarchy of the human natural killer cell response is determined by class and quantity of inhibitory receptors for self-HLA-B and HLA-C ligands.
Yu J; Heller G; Chewning J; Kim S; Yokoyama WM; Hsu KC
J Immunol; 2007 Nov; 179(9):5977-89. PubMed ID: 17947671
[TBL] [Abstract][Full Text] [Related]
57. Increased prevalence of systemic sclerosis in a Native American tribe in Oklahoma. Association with an Amerindian HLA haplotype.
Arnett FC; Howard RF; Tan F; Moulds JM; Bias WB; Durban E; Cameron HD; Paxton G; Hodge TJ; Weathers PE; Reveille JD
Arthritis Rheum; 1996 Aug; 39(8):1362-70. PubMed ID: 8702445
[TBL] [Abstract][Full Text] [Related]
58. Genetic profiles of killer-cell immunoglobulin-like receptors and HLA ligands in Thai blood donors.
Kitpoka P; Tammakorn C; Chaisri S; Leelayuwat C; Mongkolsuk T; Thammanichanond D
Hum Immunol; 2016 Jun; 77(6):470-5. PubMed ID: 27131859
[TBL] [Abstract][Full Text] [Related]
59. Receptor systems controlling natural killer cell function are genetically stratified in Europe.
Guinan KJ; Cunningham RT; Meenagh A; Dring MM; Middleton D; Gardiner CM
Genes Immun; 2010 Jan; 11(1):67-78. PubMed ID: 19693090
[TBL] [Abstract][Full Text] [Related]
60. Killer immunoglobulin-like receptor locus polymorphisms in multiple sclerosis.
Jelcić I; Hsu KC; Kakalacheva K; Breiden P; Dupont B; Uhrberg M; Martin R; Münz C; Lünemann JD
Mult Scler; 2012 Jul; 18(7):951-8. PubMed ID: 22185807
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
